Salivary C- Reactive Protein, Mean Platelet Volume and Neutrophil Lymphocyte Ratio as Diagnostic Markers for Neonatal Sepsis
Salivary C-reactive Protein,Mean Platelet Volume and Neutrophil Lymphocyte Ratio as Diagnostic Markers for Neonatal Sepsis
1 other identifier
observational
80
1 country
1
Brief Summary
To evaluate reliability of salivary C-reactive protein ,mean platelet volume , neutrophil -lymphocyte ratio , and platelet lymphocyte ratio in diagnosis of neonatal sepsis
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 4, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 4, 2020
CompletedFirst Submitted
Initial submission to the registry
February 26, 2021
CompletedFirst Posted
Study publicly available on registry
March 16, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 10, 2022
CompletedAugust 9, 2021
August 1, 2021
8 months
February 26, 2021
August 6, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Salivary c reactive protein in neonatal sepsis
Salivary C reactive protein of value as non invasive procedure in diagnosis of neonatal sepsis
28 days
Secondary Outcomes (1)
Mean platelet volume
28 days
Study Arms (2)
Case group of fullterm neonates with neonatal sepsis
Healthy fullterm neonates
Interventions
Salivary C reactive protein in neonatal sepsis
Eligibility Criteria
Full term neonates of both genders from birth to the 28th day of life who were admitted to Cairo University NICU with clinical features of either early- or late-onset neonatal sepsis diagnosed by culture, CRP more than 10 ,and has three or more the clinical findings of sepsis were enrolled in this study. Neonates with no symptoms or signs suggestive 0f sepsis who had been hospitalized In Cairo University Nicu . Serum CRP level for neonates in this group was negative (CRP \< 10 mg/L) as control group.
You may qualify if:
- \- Full term neonates of both genders from birth to the 28th day of life diagnosed with sepsis by history, clinical findings, laboratory findings, and blood culture. The clinical findings included the presence of three or more of the following:
- (1) temperature instability (hypothermia, hyperthermia) .
- (2) respiratory alterations (grunting, intercostal retractions, apnea, tachypnea, cyanosis) .
- (3) cardiovascular alterations (bradycardia, tachycardia, poor perfusion, hypotension) .
- (4) neurologic alterations (hypotonia, lethargy, seizures)
- (5) gastrointestinal alterations (feeding intolerance, abdominal distension). CRP values \>10 mg/L were considered to be positive.
You may not qualify if:
- \- Preterm neonates .
- Neonates with CNS malformations, metabolic disorders, chromosomal abnormalities, intrauterine growth restriction, or birth asphyxia were excluded from the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Faculty of medicine
Cairo, Almanyal, 11562, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Emergency medicine and traumatology resident in sharq el madina hospital
Study Record Dates
First Submitted
February 26, 2021
First Posted
March 16, 2021
Study Start
April 4, 2020
Primary Completion
December 4, 2020
Study Completion
January 10, 2022
Last Updated
August 9, 2021
Record last verified: 2021-08